Humana (HUM) Capital Expenditures (2009 - 2026)

Humana has reported Capital Expenditures for 18 years, with the latest figure at $121.0 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures rose 27.37% year-over-year to $121.0 million; the trailing twelve-month figure through Mar 2026 stood at $572.0 million (up 16.02% YoY), and the FY2025 full-year result was $546.0 million, down 5.04% from the prior year.
• Capital Expenditures for Q1 2026 stood at $121.0 million, down from $202.0 million in the prior quarter.
• The five-year high for Capital Expenditures was $295.0 million in Q1 2022, with the low at $95.0 million in Q1 2025.
• Average Capital Expenditures over 5 years is $199.0 million, with a median of $202.0 million recorded in 2025.
• Year-over-year, Capital Expenditures tumbled 56.82% in 2024 and soared 31.17% in 2025.
• Tracing HUM's Capital Expenditures over 5 years: stood at $275.0 million in 2022, then climbed by 2.91% to $283.0 million in 2023, then tumbled by 45.58% to $154.0 million in 2024, then surged by 31.17% to $202.0 million in 2025, then plunged by 40.1% to $121.0 million in 2026.
• The last three Capital Expenditures figures came in at $121.0 million (Q1 2026), $202.0 million (Q4 2025), and $135.0 million (Q3 2025), per Business Quant data.

Peer Comparison